Details of the Drug
General Information of Drug (ID: DMEDRAX)
Drug Name |
4-Amino-3-(5-methyl-thiophen-2-yl)-butyric acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
133933-77-4; CHEMBL86144; 4-amino-3-(5-methylthiophen-2-yl)butanoic acid; 4-Amtba; 4-Amino-3-(5-methyl-2-thienyl)butyric acid; AC1L2PFE; ACMC-1C1U4; 4-Amino-3-(5-methyl-thiophen-2-yl)-butyric acid; SCHEMBL341475; CTK0H6620; beta-(5-Methyl-2-thienyl)GABA; BDBM50007107; AKOS022919013; 4-amino-3-(5-methylthien-2-yl)butanoic acid; 2-Thiophenepropanoic acid, beta-(aminomethyl)-5-methyl-, (+-)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 199.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||